v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Restricted Stock Unit Awards
At The Market Offerings
Earnout Shares [Member]
Class A Common Stock
Common Stock [Member]
At The Market Offerings
Common Stock [Member]
Earnout Shares [Member]
Common Stock [Member]
Class A Common Stock
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
At The Market Offerings
Additional Paid-in Capital [Member]
Earnout Shares [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Beginning balance, common stock (in shares) at Dec. 31, 2024               188,114,000          
Beginning balance, common stock at Dec. 31, 2024 $ 348,013             $ 22 $ 732,784     $ (384,786) $ (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock under employee stock option and stock award plans (in shares)               3,649,000          
Issuance of common stock under employee stock option and stock award plans 3,979               3,979        
Stock-based compensation expense related to employee and non-employee stock awards 7,003               7,003        
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (346)               (346)        
Net loss (16,829)                     (16,829)  
Ending balance, common stock (in shares) at Mar. 31, 2025               191,763,000          
Ending balance, common stock at Mar. 31, 2025 341,820             $ 22 743,420     (401,615) (7)
Beginning balance, common stock (in shares) at Dec. 31, 2024               188,114,000          
Beginning balance, common stock at Dec. 31, 2024 348,013             $ 22 732,784     (384,786) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (85,138)                        
Ending balance, common stock (in shares) at Sep. 30, 2025               214,939,000          
Ending balance, common stock at Sep. 30, 2025 370,985             $ 24 840,892     (469,924) (7)
Beginning balance, common stock (in shares) at Mar. 31, 2025               191,763,000          
Beginning balance, common stock at Mar. 31, 2025 341,820             $ 22 743,420     (401,615) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock under employee stock option and stock award plans (in shares)               1,540,000          
Issuance of common stock under employee stock option and stock award plans 889               889        
Stock-based compensation expense related to employee and non-employee stock awards 100,000               99,998        
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (2,904)               (2,904)        
Shares issued in connection with buyout agreement/ public offering (in shares)           19,781,000              
Shares issued in connection with buyout agreement/ public offering (1,853)         $ 2     (1,853)        
Net loss (49,075)                     (49,075)  
Ending balance, common stock (in shares) at Jun. 30, 2025               213,084,000          
Ending balance, common stock at Jun. 30, 2025 388,877             $ 24 839,550     (450,690) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock under employee stock option and stock award plans (in shares)               1,855,000          
Issuance of common stock under employee stock option and stock award plans 816               816        
Stock-based compensation expense related to employee and non-employee stock awards 526               526        
Net loss (19,234)                     (19,234)  
Ending balance, common stock (in shares) at Sep. 30, 2025               214,939,000          
Ending balance, common stock at Sep. 30, 2025 370,985             $ 24 840,892     (469,924) (7)
Beginning balance, common stock (in shares) at Dec. 31, 2025         230,525,464     230,525,000          
Beginning balance, common stock at Dec. 31, 2025 443,661             $ 26 945,381     (501,739) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock under employee stock option and stock award plans (in shares)               1,480,000          
Issuance of common stock under employee stock option and stock award plans 803               803        
Stock-based compensation expense related to employee and non-employee stock awards 9,370               9,370        
Net loss (33,785)                     (33,785)  
Ending balance, common stock (in shares) at Mar. 31, 2026               232,005,000          
Ending balance, common stock at Mar. 31, 2026 420,049             $ 26 955,554     (535,524) (7)
Beginning balance, common stock (in shares) at Dec. 31, 2025         230,525,464     230,525,000          
Beginning balance, common stock at Dec. 31, 2025 443,661             $ 26 945,381     (501,739) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (299,111)                        
Ending balance, common stock (in shares) at Sep. 30, 2026         262,162,970     262,163,000          
Ending balance, common stock at Sep. 30, 2026 771,624             $ 26 1,572,455     (800,850) (7)
Beginning balance, common stock (in shares) at Mar. 31, 2026               232,005,000          
Beginning balance, common stock at Mar. 31, 2026 420,049             $ 26 955,554     (535,524) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock under employee stock option and stock award plans (in shares)               1,953,000          
Issuance of common stock under employee stock option and stock award plans 1               1        
Stock-based compensation expense related to employee and non-employee stock awards (7,566)               (7,566)        
Shares issued in connection with buyout agreement/ public offering (in shares)           17,397,000              
Shares issued in connection with buyout agreement/ public offering 6,553   $ 380,731     $ 2 $ 2   6,553 $ 380,729      
Stock Issued During Period, Shares, Other       (229,862,000)     (9,726,000)       (229,864,000)    
Net loss (228,218)                     (228,218)  
Ending balance, common stock (in shares) at Jun. 30, 2026               261,081,000          
Ending balance, common stock at Jun. 30, 2026 801,412             $ 26 1,565,135     (763,742) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock under employee stock option and stock award plans (in shares)               1,082,000          
Issuance of common stock under employee stock option and stock award plans 608               608        
Stock-based compensation expense related to employee and non-employee stock awards (63)               (63)        
Shares issued in connection with buyout agreement/ public offering 6,775               6,775        
Net loss (37,108)                     (37,108)  
Ending balance, common stock (in shares) at Sep. 30, 2026         262,162,970     262,163,000          
Ending balance, common stock at Sep. 30, 2026 $ 771,624             $ 26 $ 1,572,455     $ (800,850) $ (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Unrecognized compensation expense   $ 49,500